EcoDrugPlus

Kinesin Family Member 5b

Ensembl ID : ENSSLUG00000016653
Gene Symbol: KIF5B
3 Cross references
236 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSSLUG00000010201
Gene Symbol: KIF5B
1 Cross references
234 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSSLUG00000013931
Gene Symbol: LTA4H
3 Cross references
203 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSSLUG00000002393
Gene Symbol: LTB4R
1 Cross references
141 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSSLUG00000002401
Gene Symbol: LTB4R
1 Cross references
141 Possible Orthologues:

Leukotriene B4 Receptor 2a

Ensembl ID : ENSSLUG00000002408
Gene Symbol: LTB4R2A
1 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSSLUG00000019237
Gene Symbol: LTB4R2B
1 Cross references
167 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSSLUG00000016847
Gene Symbol: KDM1A
3 Cross references
212 Possible Orthologues:

Lysyl Oxidase Homolog 2a-Like

Ensembl ID : ENSSLUG00000003051
Gene Symbol: LOC116034379
3 Cross references
208 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSSLUG00000006864
Gene Symbol: LOXL2
3 Cross references
213 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSSLUG00000001157
Gene Symbol: MIF
3 Cross references
229 Possible Orthologues:

Macrophage-Stimulating Protein Receptor-Like

Ensembl ID : ENSSLUG00000019075
Gene Symbol: LOC116051312
2 Cross references
188 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).